These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 30088143

  • 1. Stereotactic body radiation therapy for centrally located hepatocellular carcinoma: outcomes and toxicities.
    Lazarev S, Hardy-Abeloos C, Factor O, Rosenzweig K, Buckstein M.
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2077-2083. PubMed ID: 30088143
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS, Lu HZ, Cheng T, Zhou Y, Huang Y, Gao YC, Tang MY, Jiang HY, Lian ZP, Hou EC, Liang P.
    BMC Cancer; 2016 Nov 03; 16(1):834. PubMed ID: 27809890
    [Abstract] [Full Text] [Related]

  • 9. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients.
    Sanuki N, Takeda A, Oku Y, Mizuno T, Aoki Y, Eriguchi T, Iwabuchi S, Kunieda E.
    Acta Oncol; 2014 Mar 03; 53(3):399-404. PubMed ID: 23962244
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Albumin - bilirubin (ALBI) versus Child-Turcotte-Pugh (CTP) in prognosis of HCC after stereotactic body radiation therapy.
    Su TS, Yang HM, Zhou Y, Huang Y, Liang P, Cheng T, Chen L, Li LQ, Liang SX.
    Radiat Oncol; 2019 Mar 27; 14(1):50. PubMed ID: 30917853
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
    Long Y, Liang Y, Li S, Guo J, Wang Y, Luo Y, Wu Y.
    Radiat Oncol; 2021 Apr 08; 16(1):68. PubMed ID: 33832536
    [Abstract] [Full Text] [Related]

  • 14. Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment.
    Nabavizadeh N, Waller JG, Fain R, Chen Y, Degnin CR, Elliott DA, Mullins BT, Patel IA, Dyer BA, Fakhoury K, Naugler WE, Farsad K, Tanyi JA, Fuss M, Thomas CR, Hung AY.
    Int J Radiat Oncol Biol Phys; 2018 Mar 01; 100(3):577-585. PubMed ID: 29413273
    [Abstract] [Full Text] [Related]

  • 15. Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma.
    Cárdenes HR, Price TR, Perkins SM, Maluccio M, Kwo P, Breen TE, Henderson MA, Schefter TE, Tudor K, Deluca J, Johnstone PA.
    Clin Transl Oncol; 2010 Mar 01; 12(3):218-25. PubMed ID: 20231127
    [Abstract] [Full Text] [Related]

  • 16. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.
    Kim N, Cheng J, Jung I, Liang J, Shih YL, Huang WY, Kimura T, Lee VHF, Zeng ZC, Zhenggan R, Kay CS, Heo SJ, Won JY, Seong J.
    J Hepatol; 2020 Jul 01; 73(1):121-129. PubMed ID: 32165253
    [Abstract] [Full Text] [Related]

  • 17. Stereotactic Body Radiotherapy for Small Unresectable Hepatocellular Carcinomas.
    Yeung R, Beaton L, Rackley T, Weber B, Hamm J, Lee R, Camborde M, Pearson M, Duzenli C, Loewen SK, Liu M, Ma R, Schellenberg D.
    Clin Oncol (R Coll Radiol); 2019 Jun 01; 31(6):365-373. PubMed ID: 30792051
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion.
    Mathew AS, Atenafu EG, Owen D, Maurino C, Brade A, Brierley J, Dinniwell R, Kim J, Cho C, Ringash J, Wong R, Cuneo K, Feng M, Lawrence TS, Dawson LA.
    Eur J Cancer; 2020 Jul 01; 134():41-51. PubMed ID: 32460180
    [Abstract] [Full Text] [Related]

  • 20. High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma.
    Jang WI, Kim MS, Bae SH, Cho CK, Yoo HJ, Seo YS, Kang JK, Kim SY, Lee DH, Han CJ, Kim J, Park SC, Kim SB, Cho EH, Kim YH.
    Radiat Oncol; 2013 Oct 27; 8():250. PubMed ID: 24160944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.